Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor. [electronic resource]
- Journal of virology Nov 2015
- 11457-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-5514
10.1128/JVI.01384-15 doi
Amino Acid Sequence Base Sequence CCR5 Receptor Antagonists--therapeutic use Clinical Trials as Topic Cyclohexanes--therapeutic use Drug Resistance, Viral--genetics Glycosylation HIV Envelope Protein gp120--genetics HIV Envelope Protein gp41--genetics HIV Fusion Inhibitors--therapeutic use HIV Infections--drug therapy HIV-1--drug effects Humans Maraviroc Molecular Sequence Data Protein Structure, Tertiary Receptors, CCR5--metabolism Receptors, CXCR4--metabolism Sequence Alignment Sequence Analysis, RNA Signal Transduction--genetics Treatment Failure Triazoles--therapeutic use Virus Internalization--drug effects Virus Replication--genetics